Safety and efficacy of anakinra as first-line or second-line therapy for systemic onset juvenile idiopathic arthritis – data from the German BIKER registry - Atemnkeng Ntam, V; Klein, A; Horneff, G (Expert Opin Drug Saf, 2021)